Literature DB >> 21709984

[Primary healthcare: a multidimensional study on challenges and potential in the São Paulo Metropolitan Region (SP, Brazil)].

Luiza Sterman Heimann1, Lauro Cesar Ibanhes, Roberta Cristina Boaretto, Iracema Ester do Nascimento Castro, Emilio Telesi Júnior, Carlos Tato Cortizo, Márcia Cristina Rodrigues Fausto, Vânia Barbosa do Nascimento, Jorge Kayano.   

Abstract

This paper presents some results of a case study in the Metropolitan Region of São Paulo (SP, Brazil) as part of a multicentric study conducted in Argentina, Brazil, Paraguay and Uruguay. The aim is to evaluate Primary Health Care (PHC) as a strategy to achieve integrated and universal healthcare systems. The methodological approach was based on five analytical dimensions: stewardship capability; financing; provision; comprehensiveness and intersectoral approach. The techniques included literature review, document analysis and interviews with key informants: policy makers; managers, experts, users and professionals. The results were organized in response to the challenges and possibilities of PHC as a structural system according to the five dimensions. The following emerged from the interviews: different interpretations on the concept and role of PHC and a consensus as the gateway to the system; weaknesses in funding; challenges in health workforce administration and the need for new legal-institutional design for regional management. The potential aspects were: broader coverage/universality, PHC as the basis for the organization of the system; connection with the territory and understanding specific population needs.

Entities:  

Mesh:

Year:  2011        PMID: 21709984     DOI: 10.1590/s1413-81232011000600025

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Evaluation of the performance of actions and outcomes in primary health care.

Authors:  Paula Vitali Miclos; Maria Cristina Marino Calvo; Claudia Flemming Colussi
Journal:  Rev Saude Publica       Date:  2017-09-21       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.